Author:
Jermy B. Rabindran,Khan F.A.,Ravinayagam Vijaya,Almessiere M.A.,Slimani Y.,Hassan M.,Homeida A.M.,Al-Suhaimi E.A.,Baykal A.
Reference80 articles.
1. Special issue “cisplatin in cancer therapy: molecular mechanisms of action 3.0;Gandin;Int. J. Mol. Sci.,2023
2. Cisplatin toxicity is counteracted by the activation of the p38/ATF-7 signaling pathway in post-mitotic C. elegans;Raj;Nat. Commun.,2023
3. ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer;Xiao;Proc. Natl. Acad. Sci.,2021
4. Cisplatin-induced ototoxicity: a concise review of the burden;Chattaraj;Prev., Intercept. Strateg., JCO Oncol. Pract.,2023
5. Mechanisms of cisplatin-induced acute kidney injury: pathological mechanisms, pharmacological interventions, and genetic mitigations;McSweeney;Cancers,2021